LICENSE AND COMMERCIALIZATION AGREEMENTLicense and Commercialization Agreement • November 6th, 2020 • Amag Pharmaceuticals, Inc. • Pharmaceutical preparations
This License and Commercialization Agreement (“Agreement”), effective as of July 23, 2020 (the “Effective Date”), is entered into by and between AMAG Pharmaceuticals Inc., a Delaware corporation (“AMAG Parent”) and Perosphere Pharmaceuticals Inc., a Delaware corporation (“AMAG Subsidiary” and, together with AMAG Parent, collectively “AMAG”), each with a place of business at 1100 Winter Street, Waltham, MA 02451 USA, and Norgine B.V. (“Norgine”), a Dutch corporation with a place of business at Antonio Vivaldistraat 150, 1083 HP Amsterdam, The Netherlands. AMAG and Norgine may be referred to herein individually as a “Party” or collectively as the “Parties.”
